Non-steroidal anti-inflammatory agents and coronary heart disease.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000097:blood / Q000150:complications*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D002340:Carotid Artery Diseases / Q000188:drug therapy; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005337:Fibrin / Q000502:physiology; D006801:Humans; D008297:Male; D011453:Prostaglandins / Q000096:biosynthesis; D012737:Sex Factors; D013442:Sulfinpyrazone / Q000494:pharmacology; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology
D000893:Anti-Inflammatory Agents; D011453:Prostaglandins; D004176:Dipyridamole; D005337:Fibrin; D001241:Aspirin; D013442:Sulfinpyrazone